Highlights Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 04:35:05 08/05/2026 pm IST			5-day change	1st Jan Change
1,847.90 ^INR	+0.74%		+1.34%	+7.45%

30/04	Sun Pharma, Lilly Lead Latest Healthcare Deal Rush	MT
28/04	Health Care Up on Deal Activity -- Health Care Roundup	DJ

Highlights

27/04	PRESS DIGEST-Wall Street Journal - April 27	RE
27/04	Sun Pharmaceutical to Acquire US-Based Organon in $11.8 Billion Deal	MT
27/04	Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal	RE
24/04	Sun Pharma incorporates Sun Pharma America, Inc. in United States	RE
24/04	Sun Pharmaceutical Industries Forms New Wholly-Owned Subsidiary in US; Shares Down 4%	MT
27/03	Sun Pharmaceutical Industries Limited Highlights Advances In Alopecia Areata, Psoriasis, And Acne Research At 2026 AAD Annual Meeting	CI
21/03	Sun Pharmaceutical Industries Limited Launches Semaglutide Injection Under the Brand Names Noveltreat and Sematrinity in India	CI
16/03	Sun Pharma announces US FDA acceptance of supplemental biologics license (SBLA) application for Ilumya® (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis	RE
16/03	Sun Pharmaceutical Industries Limited Announces Us Fda Acceptance of Supplemental Biologics License Application for Ilumya for Treatment of Adults with Active Psoriatic Arthritis	CI
27/02	Sun Pharmaceutical Industries Limited Showcases Data Across Its Dermatology & Immunology Portfolio At 2026 Winter Clinical Miami	CI
05/02	For interim dividend	FA
02/02	Sun Pharmaceutical Posts Higher Fiscal Q3 Consolidated Net Profit, Declares Interim Dividend	MT
01/02	Sun Pharmaceutical Seeks Acquisitions	CI
31/01	Sun Pharmaceutical Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
31/01	Sun Pharmaceutical Industries Limited Approves an Interim Dividend for the Financial Year 2025 - 2026, Payable on or Before 16 February 2026	CI
27/01	China halts sale of Sun Pharma drug used to treat dementia	RE
23/01	Sun Pharmaceutical Industries Limited Receives Dcgi Approval to Manufacture and Market Generic Semaglutide Injection in India for Chronic Weight Management	CI
23/01	Sun Pharmaceutical Gets Approval from Indian Regulator for Generic of Semaglutide Injection	MT
19/01	Sun Pharma states Organon acquisition news is speculative	RE
16/01	Sun Pharmaceutical Industries Limited Announces the Availability of UNLOXCYT (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma	CI
07/01	Sun Pharma Canada Inc. Announces Availability Of ILUMYA Pen For Moderate-To-Severe Plaque Psoriasis	CI
18/12	Sun Pharmaceutical's Baska Facility Receives 'Official Action Indicated' Status From US FDA	MT
01/12	Sun Pharma Introduces Its Global Innovative Drug, Ilumya in India for Treatment of Moderate-To-Severe Plaque Psoriasis	CI
26/11	Sun Pharmaceutical Industries Limited Announces Updated Label for Unloxcyt?	CI
12/11	Sun Pharmaceutical Industries Limited Presents Data from Phase 1b/2a Study of GL0034 at the American Heart Association 2025 Scientific Sessions	CI